Ticker
Study: Vaccine delays 'to cost EU €100bn'
By EUobserver
The slow pace of vaccination in the EU compared to the US and UK meant the bloc would likely have to keep lockdowns one to two months longer, at a cost of some €100bn to the European economy, according to a study by Bloomberg on Wednesday. The EU had vaccinated fewer than five percent of citizens by 1 February, compared to 15 percent in Britain, and 10 percent in America.